STOCK BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Cumulatively Granted Stock Options and Restricted Stock Awards, Net of Forfeitures

The following table presents the amount of cumulatively granted stock options and restricted stock awards, net of forfeitures, through December 31, 2016:

	Authorized Awards	Cumulative Granted, Net of Forfeitures		Total	Authorized but Unissued
		Stock Option  Awards	Restricted Stock  Awards
2005 Plan	1,650,000	537,941	650,485	1,188,426	461,574
2010 Plan	314,600	37,000	86,245	123,245	191,355

Schedule of Pre-tax Compensation Expense and Related Tax Benefits

The following table presents the pre-tax expense associated with stock option and restricted stock awards and the related tax benefits recognized for the years presented:

	Years Ended December 31
	2016		2015		2014
	(Dollars in thousands)
Stock based compensation expense
Stock options	$	—	$	—	$	36
Restricted stock awards(1)	2,590		2,296		2,135
Directors’ fee expense
Stock options	72		—		14
Restricted stock awards	303		194		527
Total stock based award expense	$	2,965	$	2,490	$	2,712
Related tax benefits recognized in earnings	$	1,211	$	1,122	$	945

(1) Inclusive of compensation expense associated with time-vested and performance-based restricted stock awards.

Schedule of Stock Options Granted

The Company made the following awards of nonqualified options to purchase shares of common stock in 2016. There were no such awards made in 2015 or 2014.

	Year Ended December 31, 2016
Date of grant	7/14/2016			2/20/2016
Plan	2010			2010
Options granted	5,000			5,000
Vesting period (beginning on the grant date)	18 months			22 months
Expiration date	7/14/2026			2/20/2026
Expected volatility	32.28		%	32.44		%
Expected life (years)	5.5			5.5
Expected dividend yield	2.37		%	2.28		%
Risk free interest rate	1.14		%	1.29		%
Fair value per option	$	11.46		$	10.59

Schedule of Relevant Information Relating to Stock Options

The following table presents relevant information relating to the Company’s stock options for the periods indicated:

	Years Ended December 31
	2016		2015		2014
	(Dollars in thousands, except per share data)
Fair value of stock options vested based on grant date fair value	$	37	$	14	$	211
Intrinsic value of stock options exercised	$	494	$	3,362	$	1,210
Cash received from stock option exercises	$	680	$	6,105	$	6,285
Tax benefit realized on stock option exercises/repurchase	$	204	$	1,362	$	442
Weighted average grant date fair value of options granted (per share)	$	11.03	$	—	$	—

Schedule of Stock Options

A summary of stock option activity of the Company’s Stock Option Grants for the year ended December 31, 2016 is presented in the table below:

	Outstanding								Nonvested
	Stock Option Awards			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value (1)		Stock Option Awards		Weighted Average Grant Date Fair Value
	(Dollars in thousands, except per share data)
Balance at January 1, 2016	121,900			$	28.76				—		$	—
Granted	10,000			45.69					10,000		11.03
Exercised	(22,250	)		30.58					—		—
Vested	n/a			n/a					(3,334	)	11.03
Forfeited	—			—					—		—
Expired	—			—					—		—
Balance at December 31, 2016	109,650		(2)	$	29.93	3.02 years	$	4,443	6,666		$	11.03
Options outstanding and expected to vest at December 31, 2016	109,498		(3)	$	29.91	3.01 years	$	4,439
Options exercisable at December 31, 2016	102,984		(4)	$	28.91	2.61 years	$	4,278
Unrecognized compensation cost, including forfeiture estimate													$	37
Weighted average remaining recognition period (years)													1.01 years

(1) The aggregate intrinsic value in the preceding tables represents the total pre-tax intrinsic value, based on the average of the high price and low price at which the Company’s common stock traded on December 31, 2016 of $70.45, which would have been received by the option holders had they all exercised their options as of that date.

(2) Inclusive of 34,000 stock options outstanding to Directors.

(3) Inclusive of 33,848 vested stock options and expected to vest to Directors.

(4) Inclusive of 27,334 vested stock options outstanding to Directors.

Schedule of Restricted Stock Granted

The Company grants both time-vested restricted stock awards as well as performance-based restricted stock awards. During the years ended December 31, 2016, 2015, and 2014 the Company has made the following restricted stock award grants:

	Shares Granted	Plan	Fair Value (1)		Vesting Period
Time-vested
2016
2/11/2016	51,475	2005	$	41.96	Ratably over 5 years from grant date
3/1/2016	600	2005	$	44.37	Ratably over 5 years from grant date
5/24/2016	8,700	2010	$	48.34	At the end of 5 years from grant date (2)
9/19/2016	800	2005	$	52.92	Ratably over 5 years from grant date
11/7/2016	500	2005	$	54.28	Ratably over 5 years from grant date
11/14/2016	725	2010	$	63.43	Once on May 24, 2021 (3)
2015
2/11/2015	31,500	2005	$	39.42	Ratably over 5 years from grant date
2/12/2015	25,910	2005	$	40.03	Ratably over 5 years from grant date
3/19/2015	3,800	2005	$	43.56	Ratably over 5 years from grant date
4/27/2015	625	2005	$	41.61	At the end of 3 years from grant date
4/27/2015	1,875	2005	$	41.61	At the end of 5 years from grant date
5/27/2015	8,800	2010	$	45.02	At the end of 5 years from grant date (2)
7/14/2015	800	2010	$	47.82	Once on May 27, 2020 (4)
10/13/2015	1,000	2005	$	46.09	Ratably over 5 years from grant date
10/20/2015	2,000	2005	$	46.47	Ratably over 5 years from grant date
2014
3/20/2014	65,950	2005	$	39.82	Ratably over 5 years from grant date
3/31/2014	3,000	2005	$	39.00	Ratably over 3 years from grant date
5/20/2014	10,920	2010	$	35.08	At the end of 5 years from grant date (2)
11/20/2014	2,000	2005	$	39.11	Ratably over 5 years from grant date
12/11/2014	2,000	2005	$	40.89	Ratably over 5 years from grant date
Performance-based
2016
2/11/2016	20,450	2005	$	41.96	The earlier of: the date on which it is determined if the performance goal has been achieved; or, March 31, 2019.
2015
2/12/2015	21,780	2005	$	40.03	The earlier of: the date on which it is determined if the performance goal has been achieved; or, March 31, 2018.
2014
3/20/2014	20,700	2005	$	39.82	The earlier of: the date on which it is determined if the performance goal has been achieved; or, March 31, 2017.

(1) The fair value of the restricted stock awards are based upon the average of the high and low prices at which the Company’s common stock traded on the date of grant. The holders of time-vested restricted stock awards participate fully in the rewards of stock ownership of the Company, including voting and dividend rights. The holders of performance-based restricted stock awards do not participate in the rewards of stock ownership of the Company until vested. The holders of all restricted stock awards are not required to pay any consideration to the Company for the awards.

(2) These restricted stock grants will vest at the end of a five year period, or earlier if the director ceases to be a director for any reason other than cause, such as, for example, by retirement.

(3) These restricted stock grants will vest on May 24, 2021, or earlier if the director ceases to be a director for any reason other than cause, such as, for example, by retirement.

(4) These restricted stock grants will vest on May 27, 2020, or earlier if the director ceases to be a director for any reason other than cause, such as, for example, by retirement.

Schedule of Share-based Compensation, Fair Value of Restricted Stock Awards Vesting [Table Text Block]

The following table presents the fair value of restricted stock awards vesting during the periods presented:

	Years Ended December 31
	2016		2015		2014
	(Dollars in thousands)
Fair value of restricted stock awards upon vesting	$	3,019	$	2,610	$	3,293

^[1]

Schedule of Restricted Stock Awards

A summary of the status of the Company’s Restricted Stock Award Grants for the year ended December 31, 2016 is presented in the table below:

	Outstanding Restricted Stock Awards			Weighted Average Grant Price ($)
	(Dollars in thousands, except per share data)
Balance at January 1, 2016	264,944			$	36.03
Granted	83,250			43.01
Vested/released	(67,242	)		32.96
Forfeited	(16,637	)		38.06
Balance at December 31, 2016	264,315		(1)	$	38.88
Unrecognized compensation cost (inclusive of directors’ fees), including forfeiture estimate						$	6,268
Weighted average remaining recognition period (years)						2.88

(1) Inclusive of 47,325 restricted stock awards outstanding to Directors.

[1] These restricted stock grants will vest on May 27, 2020, or earlier if the director ceases to be a director for any reason other than cause, such as, for example, by retirement.